231 related articles for article (PubMed ID: 18023249)
1. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
de Groote P; Isnard R; Assyag P; Clerson P; Ducardonnet A; Galinier M; Jondeau G; Leurs I; Thébaut JF; Komajda M
Eur J Heart Fail; 2007 Dec; 9(12):1205-11. PubMed ID: 18023249
[TBL] [Abstract][Full Text] [Related]
2. Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality.
Remme WJ
Eur J Heart Fail; 2007 Dec; 9(12):1143-5. PubMed ID: 17936067
[No Abstract] [Full Text] [Related]
3. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
4. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme.
de Groote P; Isnard R; Clerson P; Jondeau G; Galinier M; Assyag P; Demil N; Ducardonnet A; Thebaut JF; Komajda M
Eur J Heart Fail; 2009 Jan; 11(1):85-91. PubMed ID: 19147461
[TBL] [Abstract][Full Text] [Related]
6. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
[TBL] [Abstract][Full Text] [Related]
7. [Combination therapy of beta blockers for heart failure].
Watanabe M; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy with ARB for heart failure].
Sakata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
[No Abstract] [Full Text] [Related]
10. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological therapy of chronic heart failure in the elderly].
Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
[TBL] [Abstract][Full Text] [Related]
12. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
[TBL] [Abstract][Full Text] [Related]
13. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
Matthews JC; Johnson ML; Koelling TM
Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
[TBL] [Abstract][Full Text] [Related]
15. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
[TBL] [Abstract][Full Text] [Related]
16. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
Andersson B; Kjörk E; Brunlöf G
Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
[TBL] [Abstract][Full Text] [Related]
17. Conclusions on the management of heart failure.
Swedberg K
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
[TBL] [Abstract][Full Text] [Related]
18. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
Belenkov IuN; Mareev VIu; Skvortsov AA
Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
[No Abstract] [Full Text] [Related]
19. [Medical management of chronic systolic heart failure].
Galinier M
Rev Prat; 2010 Sep; 60(7):941-6. PubMed ID: 21033491
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment for chronic systolic heart failure.
Mörike K; Sindermann JR
Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
